Synthesis and bioassay of β-(1,4)-D-mannans as potential agents against Alzheimer's disease

Acta Pharmacol Sin. 2013 Dec;34(12):1585-91. doi: 10.1038/aps.2013.104. Epub 2013 Nov 18.

Abstract

Aim: Oligomannurarate 971 derived from a marine plant has shown neuroprotective effects. In this study we synthesized a series of truncated derivatives of the oligosaccharide, and investigated the effect of these derivatives against Aβ peptide toxicity in vitro.

Methods: The sulfoxide method was applied to synthesize the derivatives. SH-SY5Y human neuroblastoma cells were treated with Aβ1-40 (2 μmol/L), and the cell viability was detected using a CCK8 assay.

Results: A series of β-(1,4)-D-mannosyl oligosaccharide, ranging from the disaccharide to the hexasaccharide, were synthesized. Addition of 10 μmol/L β-(1,4)-D-mannobiose 6, β-(1,4)-D-mannotriose 9 or β-(1,4)-D-mannotetraose 12 in SH-SY5Y cells significantly attenuated Aβ1-40-induced toxicity. The efficacies were similar to those caused by 10 μmol/L oligomannurarate 971 or alzhemed. Other oligosaccharides including oligomaltoses and oligocelluloses were less active.

Conclusion: Synthetic homogeneous short chain β-(1,4)-D-mannans shows neuroprotective effect against Aβ peptide toxicity similar to that of heterogeneous oligomannurarate 971 and alzhemed.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease / drug therapy*
  • Biological Assay
  • Carbohydrate Sequence
  • Humans
  • Mannans / chemistry
  • Mannans / therapeutic use*
  • Molecular Sequence Data
  • Neuroprotective Agents / chemistry
  • Neuroprotective Agents / therapeutic use*

Substances

  • Mannans
  • Neuroprotective Agents